Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer [Phase 2]
Phase 2 trial assessing paricalcitol and hydroxychloroquine in combination with gemcitabine and nab-paclitaxel for advanced pancreatic cance…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma
Recruitment is ongoing for a clinical trial studying the relationship between genomic polymorphisms and cancer cachexia in patients with pan…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3) [Phase 3]
Phase 3 PANOVA-3 trial evaluated tumor treating fields (150 kHz) added to gemcitabine and nab-paclitaxel as front-line therapy for locally a…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma [Phase 3]
Phase 3 trial comparing gemcitabine plus paclitaxel versus gemcitabine alone after FOLFIRINOX failure in metastatic pancreatic adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Metastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate [Phase 2]
A Phase 2 clinical trial evaluating DZ-002, a heptamine carboxymethine dye conjugate, as maintenance therapy for metastatic pancreatic cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for DECOY20 with or without tislelizumab in adults with advanced solid tumors across Phase 1 and Phase 2. The listed i…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: The Seven Trial: Exploiting the Unfolded Protein Response [Phase 1]
A Phase 1 clinical trial called The Seven Trial is exploring exploitation of the unfolded protein response in metastatic pancreatic cancer, …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer [NA]
This clinical trial update notes that a study combining stereotactic body radiation with tumor treating fields is currently recruiting for l…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Identify microRNAs in Cachexia in Pancreatic Carcinoma
A clinical trial is evaluating microRNAs linked to cachexia in patients with resectable pancreatic adenocarcinoma; the study is currently re…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: APG-1387 Plus Chemotherapy in Advanced Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial of APG-1387 in combination with chemotherapy for advanced pancreatic adenocarcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Multimodal Deep Learning Model Predicts Pancreatic Cancer Prognosis
Completed trial evaluating a multimodal deep learning model that predicts prognosis in pancreatic adenocarcinoma. The study was conducted by…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for the PLATINUM study evaluating second-line platinum-based chemotherapy for metastatic BRCA1/2- or PALB2-associated …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Adenovirus (RGDCRAdCOX2F) [Phase 1]
Phase 1 clinical trial evaluating an adenovirus therapy, RGDCRAdCOX2F, for pancreatic adenocarcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]
APL-5125 is being studied in a Phase 1/2 trial for adults with advanced solid tumors, with recruitment ongoing across several indications in…
-
CLINICAL_TRIALS other · 2026-01-06Clinical Trial Update: Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)
This update notes a continued access program for Tumor Treating Fields in combination with gemcitabine and nab-paclitaxel for adults with lo…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: NH002-mediated Sonoporation With Chemotherapy in Advanced Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating NH002-mediated sonoporation with chemotherapy for advanced pancreatic cancer is currently not yet recrui…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy [Phase 2]
A Phase 2 clinical trial is evaluating irreversible electroporation (IRE) combined with a PD-1/CTLA-4 dual-function antibody for locally adv…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Cryoablation Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy [Phase 2]
A Phase 2 clinical trial is evaluating cryoablation combined with a PD-1/CTLA-4 dual-function antibody for locally advanced pancreatic adeno…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Phase I/IIa Study: RR001 Administered Following Chemotherapy Cycles for Patients With Locally Advanced Pancreatic Carcinoma [Phase 1, Phase 2]
A Phase I/IIa clinical trial of RR001 for locally advanced pancreatic adenocarcinoma is currently recruiting after chemotherapy cycles.
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma [Phase 2]
This update describes an ongoing Phase II clinical trial at Yale evaluating a modified FOLFIRINOX chemotherapy regimen together with stereot…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating BMS-986340 in combination with nivolumab, gemcitabine, and nab-paclitaxel for metastatic and recurrent pan…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Ongoing Phase 1/2 clinical trial evaluating Ivaltinostat with Capecitabine (or Capecitabine alone) for metastatic pancreatic adenocarcinoma;…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Pancreatic Cancer Detection Consortium
This Clinical Trial Update describes the Pancreatic Cancer Detection Consortium sponsored by City of Hope Medical Center, currently recruiti…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors [NA]
A completed clinical trial comparing robotic versus open pancreaticoduodenectomy for pancreatic and periampullary tumors.
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating telotristat ethyl for weight stability in advanced pancreatic cancer has completed with results posted.